Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) dropped -2.3772% and closed the trade at $ 0.7351. The company recorded a trading capacity of 1.26 million shares above its three months average daily volume of 768.12 thousand shares. During the last trade, shares reached to high price of $0.7700 and touched the low price of $0.7311. The stock’s 50-day moving average is noted at $2.0583 and its 200-day moving average is stands at $2.2980.
Additionally, the companyhas EPS of -2.6540. The company has market capitalization of $19.01M.
Currently Tonix Pharmaceuticals Holding Corp. (TNXP) captured an average recommendation of “ Hold ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “0″ Analysts”. “0” rated “Sell” for the company. “3” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $4.08 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $10.00 however minimum price target advised by analysts is $1.00. The Median price target for the stock is measured at $1.25.
Presently, Analysts decided consensus EPS estimate of $-0.34 for present quarter and one month ago projected EPS estimate was at $-0.37. If we take a look at back 3 month ago, consensus EPS estimate was $-0.51.
A current consensus EPS estimate for next quarter is at $-0.24 and 3 month ago EPS forecast was $-0.46. Have a look at back 1 month ago, consensus EPS forecast was seen at $-0.34.
For current fiscal year, most recent EPS estimate is set at $-1.70 based on Analyst consensus and three month ago consensus EPS opinions was at $-2.31. During period one month ago, consensus EPS forecast was decided at $-1.86.
A current consensus EPS projection for next fiscal year is observed at $-0.98 and one month ago consensus EPS forecast was at $-1.40. Take a look at back three month ago, consensus EPS estimate opinions was decided at $-1.65 by analysts.
One Month ago, the stock has gained consensus mean rating of Buy based on the analysis of brokerage analyst firms polled. 3 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 0 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Buy derived from brokerage firms, according to FactSet. 3 said a “Buy Rating” and 0 announced “Overweight Rating”. 0 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.